2021 NOSCM | New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Nicole Ianniello, PharmD
Disclosure
Nicole Ianniello, PharmD discloses no such relationships exist
Accreditation
NA
-1768573067280.webp&w=3840&q=75)
-1768572750650.webp&w=3840&q=75)